Hypodipsia discriminates progressive supranuclear palsy from other parkinsonian syndromes

Movement Disorders

Volumn 26, Issue 5, 2011, Pages 901-905

  Stamelou, Maria ^a   Christ, Helena ^a   Reuss, Alexander ^a   Oertel, Wolfgang ^a   Höglinger, Günter ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Hypodipsia; Multiple system atrophy; Parkinson's disease; Progressive supranuclear palsy; Thirst

Indexed keywords

AMANTADINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; SODIUM CHLORIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG INFUSION; FEEDING DISORDER; FEMALE; HUMAN; HYPODIPSIA; MALE; PARKINSON DISEASE; PARKINSONISM; PLASMA OSMOLALITY; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; QUESTIONNAIRE; SCORING SYSTEM; SHY DRAGER SYNDROME; THIRST; VISUAL ANALOG SCALE;

AGED; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; DRINKING; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSONIAN DISORDERS; QUESTIONNAIRES; STATISTICS AS TOPIC; SUPRANUCLEAR PALSY, PROGRESSIVE; WATER DEPRIVATION;

EID: 79955076348     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23587     Document Type: Article

References (28)

1. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996; 47: 1-9.
2. Burn DJ, Lees AJ. Progressive supranuclear palsy: where are we now? Lancet Neurol 2002; 1: 359-369.
3. Abdo WF, van de Warrenburg BP, Burn DJ, Quinn NP, Bloem BR. The clinical approach to movement disorders. Nat Rev Neurol 2010; 6: 29-37.
4. Williams DR, Lees AJ. Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol 2009; 8: 270-279.
5. Osaki Y, Ben-Shlomo Y, Lees AJ, et al. Accuracy of clinical diagnosis of progressive supranuclear palsy. Mov Disord 2004; 19: 181-189.
6. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988; 51: 745-752.
7. Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008; 71: 670-676.
8. Hoehn M, Yahr M. Parkinsonism: onset, progression, and mortality. Neurology 1967; 17: 427-442.
9. Guigoz Y, Lauque S, Vellas BJ. Identifying the elderly at risk for malnutrition. The Mini Nutritional Assessment. Clin Geriatr Med 2002; 18: 737-757.
10. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382-389.
11. Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB. A frontal assessment battery at bedside. Neurology 2000; 55: 1621-1626
12. Ponsen MM, Stoffers D, Booij J, van Eck-Smit BL, Wolters E, Berendse HW. Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol 2004; 56: 173.
13. Schmidt C, Herting B, Prieur S, et al. Autonomic dysfunction in patients with progressive supranuclear palsy. Mov Disord 2008; 23: 2083-2089.
14. Perneczky R, Diehl-Schmid J, Förstl H, Drzezga A, May F, Kurz A. Urinary incontinence and its functional anatomy in frontotemporal lobar degenerations. Eur J Nucl Med Mol Imaging 2008; 35: 605-610.
15. Blok BF, Willemsen AT, Holstege G. A PET study on brain control of micturition in humans. Brain 1997; 120: 111-121.
16. Zünd S, Fretz C, Krapf R. Acquired disorder of thirst perception with intact osmoregulation of vasopressin. Wien Klin Wochenschr 1998; 110: 538-541.
17. Franco-Saenz R, Wolffing BK, Rivers RJ. Hypodipsia and hypernatremia in congenital hydrocephalus. Am J Med Sci 1989; 297: 385-386.
18. Paviour DC, Thornton JS, Lees AJ, Jäger HR. Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy. Mov Disord 2007; 22: 68-74.
19. Rizzo G, Martinelli P, Manners D, et al. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease. Brain 2008; 131: 2690-2700.
20. Boxer AL, Geschwind MD, Belfor N, et al. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. Arch Neurol 2006; 63: 81-86.
21. Varrone A, Pagani M, Salvatore E, et al. Identification by [99mTc]ECD SPECT of anterior cingulate hypoperfusion in progressive supranuclear palsy, in comparison with Parkinson's disease. Eur J Nucl Med Mol Imaging 2007; 34: 1071-1081.
22. Braak H, Braak E. Pathoanatomy of Parkinson's disease. J Neurol 2000; 247: 3-10.
23. Denton D, Shade R, Zamarippa F, et al. Neuroimaging of genesis and satiation of thirst and an interoceptor-driven theory of origins of primary consciousness. Proc Natl Acad Sci U S A 1999; 96: 5304-5309.
24. Egan G, Silk T, Zamarripa F, et al. Neural correlates of the emergence of consciousness of thirst. Proc Natl Acad Sci U S A 2003; 100: 15241-15246.
25. Farrell MJ, Egan GF, Zamarripa F, et al. Unique, common, and interacting cortical correlates of thirst and pain. Proc Natl Acad Sci U S A 2006; 103: 2416-2421.
26. Denton D, Shade R, Zamarippa F, et al. Correlation of regional cerebral blood flow and change of plasma sodium concentration during genesis and satiation of thirst. Proc Natl Acad Sci U S A 1999; 96: 2532-2537.
27. Hollis JH, McKinley MJ, D'souza M, Kampe J, Oldfield BJ. The trajectory of sensory pathways from the lamina terminalis to the insular and cingulate cortex: a neuroanatomical framework for the generation of thirst. Am J Physiol Regul Integr Comp Physiol 2008; 294: 1390-1401.
28. Mittleman G, Rosner AL, Schaub CL. Polydipsia and dopamine: behavioral effects of dopamine D1 and D2 receptor agonists and antagonists. J Pharmacol Exp Ther 1994; 271: 638-650.